Christopher Hite, EVP & Chairman, Partnering: Royalty Pharma RPRX Sell · Filed 09/24

Trade details

Type: Insider sale
Amount: $231,402.79
Shares · price: 3,927 sh · $58.93 a share
Held after: 270,401 sh
Stock: Royalty Pharma RPRX
Person: Christopher HiteEVP & Chairman, Partnering
Trade date: 26/09/22
Filed: 26/09/24
Days to filing: 2 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 08/23~10/22

Christopher Hite's recent trades

Christopher HiteEVP & Chairman, Partnering
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$5.6M
96,073 sh
$5.6M
Filed 09/24
Traded 09/22
Christopher HiteEVP & Chairman, Partnering
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$6.4M
117,592 sh
$6.4M
Filed 06/25
Traded 06/23
Christopher HiteEVP & Chairman, Partnering
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$1.8M
32,408 sh
$1.8M
Filed 06/25
Traded 06/23
Christopher HiteEVP & Chairman, Partnering
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$1.7M
30,000 sh
$1.7M
Filed 06/23
Traded 06/23